Cis-4-amino-l-proline residue as a scaffold for the synthesis of cyclic and linear endomorphin-2 analogues: Part 2

Journal of Medicinal Chemistry

Volumn 55, Issue 19, 2012, Pages 8477-8482

  Mollica, Adriano ^a   Pinnen, Francesco ^a   Stefanucci, Azzurra ^a   Mannina, Luisa ^b,c   Sobolev, Anatoly P ^c   Lucente, Gino ^b   Davis, Peg ^d   Lai, Josephine ^d   Ma, Shou Wu ^d   Porreca, Frank ^d   Hruby, Victor J ^e  

^a UNIVERSITY OF CHIETI   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c CNR   (Italy)

^d UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^e UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIS 4 AMINO PROLINE; ENDOMORPHIN 2; MU OPIATE RECEPTOR; PROLINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CHIRALITY; CHO CELL; DRUG STRUCTURE; DRUG SYNTHESIS; LIGAND BINDING; MOUSE; NONHUMAN; RAT; RECEPTOR AFFINITY; STEREOCHEMISTRY;

ANIMALS; CELL LINE; CRICETINAE; CRICETULUS; GUINEA PIGS; ILEUM; MALE; MICE; MUSCLE CONTRACTION; MUSCLE, SMOOTH; OLIGOPEPTIDES; PEPTIDES, CYCLIC; PROLINE; PROTEIN CONFORMATION; RADIOLIGAND ASSAY; RATS; RECEPTORS, OPIOID; RECEPTORS, OPIOID, KAPPA; RECEPTORS, OPIOID, MU; RECEPTORS, SIGMA; STRUCTURE-ACTIVITY RELATIONSHIP; VAS DEFERENS;

EID: 84867389782     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm300947s     Document Type: Article

References (27)

1. Janecka, A.; Staniszewska, R.; Gash, K.; Fichna, J. Enzymatic degradation of endomorphins Peptides 2008, 29, 2066-2073
2. Egleton, R. D.; Abbruscato, T. J.; Tomas, S. A.; Davis, T. P. Transport od opioid peptides into the central nervous system J. Pharm. Sci. 1998, 87, 1433-1439
3. Spampinato, S.; Qasem, A. R.; Calienni, M.; Murari, G.; Gentilucci, L.; Tolomelli, A. Antinociception by a peripherally administered novel endomorphin-1 and endomorphin-2 analogue containing beta-proline Eur. J. Pharmacol. 2003, 469, 89-95
4. Meisenberg, G.; Simmons, W. H. Minireview. Peptides and the blood-brain barrier Life Sci. 1983, 32, 2611-2623
5. Begley, D. J. The blood-brain barrier: principles for targeting peptides and drugs to the central nervous system J. Pharm. Pharmacol. 1996, 48, 136-146
6. Schiller, P. W.; Weltrowska, G.; Schmidt, R.; Nguyen, T. M.-D.; Berezowska, I.; Lemieux, C.; Chung, N. N.; Carpenter, K. A.; Wilkes, B. C. Structural and Pharmacological Aspects of Peptidomimetics. In Drug Discovery Strategies and Methods; Makriyannis, A.; Biegel, D., Eds.; Marcel Dekker, Inc.: New York, 2004; pp 147-173.
7. Mollica, A.; Guardiani, G.; Davis, P.; Ma, S.-W.; Porreca, F.; Lai, J.; Mannina, L.; Sobolev, A. P.; Hruby, V. J. Synthesis of stable and potent δ/μ opioid peptides: Analogues of H-Tyr-c[D-Cys-Gly-Phe-D-Cys]-OH by ring-closing-metathesis J. Med. Chem. 2007, 50, 3138-3142
8. Mollica, A.; Pinnen, F.; Stefanucci, A.; Feliciani, F.; Campestre, C.; Mannina, L.; Sobolev, A. P.; Lucente, G.; Davis, P.; Lai, J.; Ma, S.-W.; Porreca, F.; Hruby, V. J. The cis -4-amino-l-proline residue as a scaffold for the synthesis of cyclic and linear endomorphin-2 analogues J. Med. Chem. 2012, 55, 3027-3035
9. 2 residue Bioorg. Med. Chem. Lett. 2009, 19, 4115-4118
10. Giordano, C.; Sansone, A.; Masi, A.; Lucente, G.; Punzi, P.; Mollica, A.; Pinnen, F.; Feliciani, F.; Cacciatore, I.; Davis, P.; Lai, J.; Ma, S.-W.; Porreca, F.; Hruby, V. J. Synthesis and activity of endomorphin-2 and morphiceptin analogues with proline surrogates in position 2 Eur. J. Med. Chem. 2010, 45, 4594-4600
11. Torino, D.; Mollica, A.; Feliciani, F.; Spisani, S.; Lucente, G. Novel chemotactic For-Met-Leu-Phe-OMe (fMLF-OMe) analogues based on Met residue replacement by 4-amino-proline scaffold: synthesis and bioactivity Bioog. Med. Chem. 2009, 17, 251-259
12. Paglialunga Paradisi, M.; Mollica, A.; Cacciatore, I.; Di Stefano, A.; Pinnen, F.; Caccuri, A. M.; Ricci, G.; Duprè, S.; Spirito, A.; Lucente, G. Proline-glutamate chimeras in isopeptides. Synthesis and biological evaluation of conformationally restricted glutathione analogues Bioorg. Med. Chem. 2003, 11, 1677-1683
13. Mollica, A.; Paglialunga Paradisi, M.; Varani, K.; Spisani, S.; Lucente, G. Chemotactic peptides: fMLF-Ome analogues incorporating proline-methionine chimeras as N-terminal residue Bioog. Med. Chem. 2006, 14, 2253-2265
14. Cardillo, G.; Gentilucci, L.; Tolomelli, A.; Spinosa, R.; Calienni, M.; Quasem, A. R.; Spampinato, S. Synthesis and evaluation of the affinity toward μ-opioid receptors of atypical, lipophilic ligands based on the sequence c[Tyr-Pro-Trp-Phe-Gly] J. Med. Chem. 2004, 47, 5198-5203
15. Gentilucci, L.; Squassabia, F.; Demarco, R.; Artali, R.; Cardillo, G.; Tolomelli, A.; Spampinato, S.; Bedini, A. Investigation of the interaction between the atypical agonist c[YpwFG] and MOR J. Med. Chem. 2008, 275, 2315-2337
16. Sasaki, J.; Matsumura, Y. New Cyclic Peptide, JP 10330398, Tokyo, 1998.
17. Goldberg, I. E.; Rossi, G. C.; Letchworth, S. R.; Mathis, J. P.; Ryan-Moro, J.; Leventhal, L.; Su, W.; Emmel, D.; Bolan, E. A.; Pasternak, G. W. Pharmacological characterization of endomorphin-1 and endomorphin-2 in mouse brain J. Pharm. Exp. Ther. 1998, 286, 1007-1013
18. Me,Me pro)-Pro] Tetrahedron 1999, 37, 11281-11288
19. Gademann, K.; Seebach, D. Preparation and NMR structure of the cyclo-β-tripeptide [β3-HGlu] in aqueous solution. A new class of enterobactin-type C3-symmetrical ligands? Helv. Chim. Acta 1999, 82, 957-962
20. Gademann, K.; Seebach, D. Synthesis of cyclo-β-tripeptides and their biological in vitro evaluation as antiproliferatives against the growth of human cancer cell lines Helv. Chim. Acta 2001, 84, 2924-2937
21. Song, Y. F.; Zhen, H. M. Synthesis and investigation of the reactive oxygen species of a novel cyclic peptide-2,6-dimethoxyhydroquinone-3- mercaptoacetic acid conjugate Chin. Chem. Lett. 2001, 12, 1075-1078
22. Nam, N.-H.; Ye, G.; Sun, G.; Parang, K. Conformationally constrained peptide analogues of pTyr.Glu-Glu-Ile as inhibitors of the Src SH2 domain binding J. Med. Chem. 2004, 47, 3131-3142
23. Bolm, C.; Meyer, N.; Raabe, G.; Weyhermüller, T.; Bothe, E. A novel enantiopure prolined-derived triazacyclononane: synthesis, structure and application of its manganese complex Chem. Commun. 2000, 24, 2435-2436
24. Torino, D.; Mollica, A.; Pinnen, F.; Feliciani, F.; Lucente, G.; Fabrizi, G.; Portalone, G.; Davis, P.; Lai, J.; Ma, S.-W.; Porreca, F.; Hruby, V. J. Synthesis and evaluation of new endomorphin-2 analogues containing (Z)-α,β-didehydrophenylalanine (ΔPhe) residues J. Med. Chem. 2010, 53, 4550-4554
25. Mollica, A.; Pinnen, F.; Feliciani, F.; Stefanucci, A.; Lucente, G.; Davis, P.; Porreca, F.; Ma, S.-W.; Lai, J.; Hruby, V. J. New potent biphalin analogues containing p -fluoro- l -phenylalanine at the 4,4′ positions and non-hydrazine linkers Amino Acids 2011, 40, 1503-1511
26. Kramer, T. H.; Davis, P.; Hruby, V. J.; Burks, T. F.; Porreca, F. In vitro potency, affinity and agonist efficacy of highly selective δ opioid receptor ligands J. Pharmacol. Exp. Ther. 1993, 266, 577-584
27. Meng, F.; Xie, G. X.; Thompson, R. C.; Mansour, A.; Goldstein, A.; Watson, S. J.; Akil, H. Cloning and pharmacological characterization of a rat k opioid receptor Proc. Natl. Acad. Sci. U.S.A. 1993, 90, 9954-9958